-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Using multi-cancer early detection testing to screen for cancers that lack recommended screenings

Sponsor: Grail, Inc
Program: Company Showcases
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Saturday, December 7, 2024: 1:30 PM-1:45 PM
Room 4 (San Diego Convention Center)
Speaker:
Megan Hall, PhD, Grail, Inc.
Disclosures:
No relevant conflicts of interest to declare.

This presentation is intended for U.S. based registered meeting attendees

For in-person participants only
See more of: Company Showcases
<< Previous Session | Next Session >>